Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Open
-
Financial Toxicity and its impact on Quality of Life in plasma cell disorders
Rochester, Minn.
The purpose of this study is to evaluate the magnitude of financial toxicity in newly diagnosed and relapsed multiple myeloma (MM) and amyloidosis (AL) patients.
-
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study) (DRAMMATIC)
Rochester, Minn.,
Eau Claire, Wis.,
Scottsdale/Phoenix, Ariz.
The primary purpose of this study is to compare overall survival between two treatment arms, with lenalidomide as the comparator arm and lenalidomide + daratumumab/rHuPH20 as the experimental arm, in post-autologous transplant multiple myeloma (MM) patients.
-
Understanding the challenges, behavioral patterns, and preferences towards participation in clinical trials in minority patient populations: Development and validation of a personalized clinical trial educational platform to boost participation among underserved cancer patients.
Jacksonville, Fla.,
Rochester, Minn.,
Scottsdale/Phoenix, Ariz.
The purpose of this study is to evaluate the challenges, behavioral patterns, and preferences of minority patient participation in clinical trials. Also, to develop and validate a personalized clinical trial educational platform to boost participation among underserved cancer patients.
.